Hydroxyurea

Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)

Study to Identify and Describe Predictive Factors for Thromboembolic Events in Patients With High-risk Polycythemia Vera

Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease

Evaluation of HU-resistance in Adult Patients With Polycythemia Vera Who Meet PV-AIM Predictors

Haploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMTCTN1507)

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease

Realizing Effectiveness Across Continents With Hydroxyurea

Alternative Dosing And Prevention of Transfusions (ADAPT)

Oral Decitabine Plus Ivosidenib as First Line for Older/Unfit Adult AML Patients

Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera

Ziftomenib for the Treatment of Patients With NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia Not Eligible for Standard Therapy

Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia

A Study of onCARlytics (CF33-CD19) in Combination With Blinatumomab in Adults With Advanced or Metastatic Solid Tumors (OASIS)

Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia

Stroke Prevention in Nigeria 2 Trial

Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer

Study of Stem Cell Transplant vs. Non-Transplant Therapies in High-Risk Myelofibrosis

Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure